Farmacie pro praxi. 2023;19(1):51-62 | DOI: 10.36290/lek.2023.008

Pharmacotherapy of infectious diarrhoea

Vilma Vranová, Karel Vašut
Ústav aplikované farmacie, Farmaceutická fakulta, Masarykova univerzita, Brno

Diarrhoeal disease is one of the most commonly occurring infectious diseases in the Czech Republic. The primary the­rapeutic goal in diarrhoea is to eliminate the causative agents, such as toxins, prevent dehydration, and protect intestinal mucosa from injury. Only when an infectious origin of diarrhoea has been confirmed, specific treatment - chemotherapeutic drugs and antibiotics - is initiated. The following overview of medicinal products and medical devices used is presented in the order that should correspond to the course of treatment in the case of acute diarrhoea of unknown origin.

Keywords: diarrhoea, rehydration, adsorbents, mucoprotective drugs.

Accepted: February 17, 2023; Published: March 3, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vranová V, Vašut K. Pharmacotherapy of infectious diarrhoea. Pharmacy for Practice. 2023;19(1):51-62. doi: 10.36290/lek.2023.008.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hamilton KW, Cifu AS. Diagnosis and Management of Infectious Diarrhea. JAMA. 2019 Mar 5;321(9):891-892. Go to original source... Go to PubMed...
    2. Moutelíková R, Blahová A, Prodělalová J. Rotaviry známé i neznámé. Pediatr. praxi. 2017;18(4):223-225 Go to original source...
    3. Gabarró MS, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European union countries. Ped Inf Dis J 2006; 25(1):7-11 Go to original source...
    4. Galanopoulos M, Gkeros F, Doukatas A, et al. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. Go to original source...
    5. Výskyt vybraných hlášených infekcí v České republice - nemocnost 2013-2022. [cit. 2023-01-23]. Available from: https://szu.cz/publikace/data/2022.
    6. Seifer, B, Beneš J, Karen I, et al. Akutní průjem u dospělých. Centrum doporučených postupů pro praktické lékaře, Společnost všeobecného lékařství 2015.
    7. SÚKL: Farmakoterapeutické informace SUKL 2011/4 [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/sukl/farmakoterapeuticke-informace.
    8. Mikolášek P. Dehydratace u dětí. Pediatr. praxi. 2018;19(5):252-255. Go to original source...
    9. SÚKL: Carbosorb. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0000982&tab=texts.
    10. SÚKL: Smecta. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0132944&tab=texts.
    11. SÚKL: Hidrasec. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0192699&tab=texts.
    12. Dle Zkrácených informací zdravotnického prostředku Tasectan.
    13. Ambrožová H. Pacient s průjmem v ordinaci praktického lékaře příčiny a řešení. Med. praxi. 2021;18(4):236-242. Go to original source...
    14. Aloi M, Mennini M. Efficacy of gelatin tannate for acute diarrhea in children: a systematic review and meta-analysis. J Comp Eff Res. 2019;8(2):91-102. Go to original source... Go to PubMed...
    15. SÚKL: Lacidofil. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0260423&tab=texts.
    16. Hayes SR, Vargas AJ. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea. Explore (NY). 2016 Nov-Dec;12(6):463-466. Go to original source... Go to PubMed...
    17. SÚKL: Mutaflor. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0107585&tab=texts.
    18. SÚKL: Enterol. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0162083.
    19. SÚKL: Hylak. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0221088&tab=texts.
    20. SÚKL: Imodium. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0132962&tab=texts.
    21. SÚKL: Reasec. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0030652&tab=texts.
    22. SÚKL: Endiaron. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0258020.
    23. Beneš J, et al. Infekční lékařství. Praha: Galén, 2009.
    24. SÚKL: Ercefuryl. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0214593.
    25. SÚKL: Normix. Souhrn údajů o přípravku. [online]. [cit. 2023-01-23]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0225543.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.